Status:
COMPLETED
Exome Evaluation in Patients Living with Diabetes Complicated by Charcot Neuroarthropathy.
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-70 years
Brief Summary
Diabetes, like obesity, has reached worldwide proportions such that we're talking about a pandemic. These two diseases are a major cause of mortality and multiple complications. The medical and financ...
Detailed Description
In patients living with diabetes, a rare and devastating joint complication known as Charcot's neuroarthropathy (CN) has been observed. The clinical presentation of this complication is characterized ...
Eligibility Criteria
Inclusion
- Men or women aged 18 to 70
- with type 2 diabetes for at least one year
- with active or chronic Charcot neuroarthropathy (Group 1) OR
- never had Charcot neuroarthropathy (Group 2)
- Have agreed to participate in the study and have signed an informed consent form.
Exclusion
- \- Subject under guardianship or curatorship.
Key Trial Info
Start Date :
July 11 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 18 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06096935
Start Date
July 11 2024
End Date
January 18 2025
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France, 91106